遗传性上腺增生和神经精神疾病之间的因果关系 - - 孟德尔随机化研究
Yang Liu1, Xiaokun Gang1, Yuan Gao1
1Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, Jilin Province, China.
与CYP21A2缺乏相关的先天性上腺增生 (CAH) 可能会降低阿尔茨海默病的风险,但会增加自闭症谱系障碍的风险,特别是通过上腺通路. 这突显了内分泌功能在神经精神疾病中的作用.
科学领域:
- 遗传学 遗传学 是一个
- 内分泌学 在内分泌学.
- 神经科学是一个神经科学.
背景情况:
- 先天性上腺增生 (CAH),主要是由于由CYP21A2突变引起的21-基酶缺乏 (21-OHD),损害皮质醇合成和上腺激素平衡.
- 观察性研究表明,CAH与神经精神疾病风险增加之间存在联系,但因果关系尚不清楚.
- 本研究研究了CAH特征的CYP21A2减少表达如何通过组织特异性机制影响精神病的结果.
研究的目的:
- 使用孟德尔随机化研究CYP21A2表达和神经精神疾病之间的因果关系.
- 探索CYP21A2缺乏对阿尔茨海默病 (AD) 和自闭症谱系障碍 (ASD) 风险的组织特异性影响.
- 确定潜在的内分泌机制,如改变的水平,将CAH与神经精神疾病联系起来.
主要方法:
- 使用来自上腺和血液组织的CYP21A2表达定量特征位点 (eQTLs) 采用双样本孟德尔随机化 (MR).
- 对CYP21A2的遗传仪器与已知的CAH生物标志物进行了验证.
- 评估了与十种神经精神疾病的关联,使用敏感性分析,包括MR-Egger,加权中位数和LD得分回归.
主要成果:
- 上腺特异性CYP21A2下调与阿尔茨海默病 (AD) 风险降低 (OR=1.245/1.100) 和自闭症谱系障碍 (ASD) 易感性增加 (OR=0.766/0.659) 相关.
- 相反,来自血液的CYP21A2eQTLs显示出相反的趋势,降低ASD风险 (OR=1.072/1.071) 和增加AD风险 (OR=0.968).
- 减少CYP21A2表达在两个组织与高的生物可用相关,与CAH病理生理学保持一致.
结论:
- 与CYP21A2缺乏相关的上腺驱动的途径可能会提供对AD的保护,同时增加ASD风险.
- 这些发现强调了内分泌因子在神经精神疾病发展中的关键作用.
- 个性化的CAH管理应该考虑整合心理健康监测,因为这些已识别的链接.
更多相关视频
05:44Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
Published on: May 17, 2024
07:38Functional Characterization of Na+/H+ Exchangers of Intracellular Compartments Using Proton-killing Selection to Express Them at the Plasma Membrane
Published on: March 30, 2015
相关概念视频
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Sex-linked Disorders
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
